Aktis Oncology, Inc.

NASDAQ:AKTS

Biotechnology

Healthcare
$16.31 +0.47%

+$0.11 today

Market cap
$876.61M
Beta
1.10
P/E (TTM)
-28.7
EPS (TTM)
-$0.82
52W Low $14.72High $29.16

Volume 0.47M

Average 0.33M

Private 5-step workspace

Build a AKTS investment thesis

Turn Aktis Oncology, Inc. research into a structured decision across business quality, moat, management, intrinsic value, and synthesis.

Log in to save your stock analysis
Your answers are private and saved per stock, so you can come back to the thesis later.